These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 11592567)

  • 1. Insufficient adrenarche in patients with combined pituitary hormone deficiency caused by a PROP-1 gene defect.
    Voutetakis A; Livadas S; Sertedaki A; Maniati-Christidi M; Dacou-Voutetakis C
    J Pediatr Endocrinol Metab; 2001; 14(8):1107-11. PubMed ID: 11592567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recovery of responses to ovine corticotropin-releasing hormone after withdrawal of a short course of glucocorticoid.
    Brigell DF; Fang VS; Rosenfield RL
    J Clin Endocrinol Metab; 1992 May; 74(5):1036-9. PubMed ID: 1314844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diminished adrenal androgen secretion in familial glucocorticoid deficiency implicates a significant role for ACTH in the induction of adrenarche.
    Weber A; Clark AJ; Perry LA; Honour JW; Savage MO
    Clin Endocrinol (Oxf); 1997 Apr; 46(4):431-7. PubMed ID: 9196605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The hypothalamic-pituitary-adrenal axis of patients with severe sepsis: altered response to corticotropin-releasing hormone.
    Schroeder S; Wichers M; Klingmüller D; Höfer M; Lehmann LE; von Spiegel T; Hering R; Putensen C; Hoeft A; Stüber F
    Crit Care Med; 2001 Feb; 29(2):310-6. PubMed ID: 11246311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-2 given to asymptomatic HIV-infected individuals leads to an exaggerated response of the pituitary gland to the action of CRH.
    Witzke O; Winterhagen T; Kribben A; Philipp T; Mann K; Reinhardt W
    Clin Endocrinol (Oxf); 2003 Jul; 59(1):104-9. PubMed ID: 12807511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of repetitive administration of corticotropin-releasing hormone combined with lysine vasopressin on plasma adrenocorticotropin and cortisol levels in secondary adrenocortical insufficiency.
    Fukata J; Usui T; Tsukada T; Nakai Y; Koh T; Ishihara T; Tanaka I; Uchida K; Yoshimasa T; Nakano R
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1624-31. PubMed ID: 2172283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central hypocortisolism as part of combined pituitary hormone deficiency due to mutations of PROP-1 gene.
    Asteria C; Oliveira JH; Abucham J; Beck-Peccoz P
    Eur J Endocrinol; 2000 Sep; 143(3):347-52. PubMed ID: 11022176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of the desmopressin test in the postoperative evaluation of patients with Cushing's disease.
    Colombo P; Dall'Asta C; Barbetta L; Re T; Passini E; Faglia G; Ambrosi B
    Eur J Endocrinol; 2000 Aug; 143(2):227-34. PubMed ID: 10913942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Placental corticotropin-releasing hormone and pituitary-adrenal function during pregnancy.
    Goland RS; Conwell IM; Warren WB; Wardlaw SL
    Neuroendocrinology; 1992 Nov; 56(5):742-9. PubMed ID: 1336818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated post-dexamethasone suppression cortisol concentrations correlate with hormonal alterations of the hypothalamo-pituitary adrenal axis in patients with adrenal incidentalomas.
    Tsagarakis S; Roboti C; Kokkoris P; Vasiliou V; Alevizaki C; Thalassinos N
    Clin Endocrinol (Oxf); 1998 Aug; 49(2):165-71. PubMed ID: 9828902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated levels of umbilical cord plasma corticotropin-releasing hormone in growth-retarded fetuses.
    Goland RS; Jozak S; Warren WB; Conwell IM; Stark RI; Tropper PJ
    J Clin Endocrinol Metab; 1993 Nov; 77(5):1174-9. PubMed ID: 8077309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute dexamethasone suppression of ACTH secretion stimulated by human corticotrophin releasing hormone, AVP and hypoglycaemia.
    Hohnloser J; Von Werder K; Müller OA
    Clin Endocrinol (Oxf); 1989 Aug; 31(2):175-84. PubMed ID: 2557988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levels of DHEA and DHEAS and responses to CRH stimulation and hydrocortisone treatment in chronic fatigue syndrome.
    Cleare AJ; O'Keane V; Miell JP
    Psychoneuroendocrinology; 2004 Jul; 29(6):724-32. PubMed ID: 15110921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgen response to hypothalamic-pituitary-adrenal stimulation with naloxone in women with myotonic muscular dystrophy.
    Buyalos RP; Jackson RV; Grice GI; Hockings GI; Torpy DJ; Fox LM; Boots LR; Azziz R
    J Clin Endocrinol Metab; 1998 Sep; 83(9):3219-24. PubMed ID: 9745431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. During a corticotropin-releasing hormone test in healthy subjects, administration of a beta-adrenergic antagonist induced secretion of cortisol and dehydroepiandrosterone sulfate and inhibited secretion of ACTH.
    Kizildere S; Glück T; Zietz B; Schölmerich J; Straub RH
    Eur J Endocrinol; 2003 Jan; 148(1):45-53. PubMed ID: 12534357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma corticotrophin releasing hormone, vasopressin, ACTH and cortisol responses to acute myocardial infarction.
    Donald RA; Crozier IG; Foy SG; Richards AM; Livesey JH; Ellis MJ; Mattioli L; Ikram H
    Clin Endocrinol (Oxf); 1994 Apr; 40(4):499-504. PubMed ID: 8187316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of parturition on corticotropin releasing hormone and products of the pituitary and adrenal in term fetuses at delivery.
    Warren WB; Goland RS
    J Perinat Med; 1995; 23(6):453-8. PubMed ID: 8904474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of alcoholism on the hypothalamic-pituitary-adrenal axis: interaction with endogenous opioid peptides.
    Inder WJ; Joyce PR; Ellis MJ; Evans MJ; Livesey JH; Donald RA
    Clin Endocrinol (Oxf); 1995 Sep; 43(3):283-90. PubMed ID: 7586596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adrenal function under long-term raloxifene administration.
    Genazzani AR; Lombardi I; Borgioli G; di Bono I; Casarosa E; Gambacciani M; Palumbo M; Genazzani AD; Luisi M
    Gynecol Endocrinol; 2003 Apr; 17(2):159-68. PubMed ID: 12737677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison between the effects of low dose (1 microg) and standard dose (250 microg) ACTH stimulation tests on adrenal P450c17alpha enzyme activity in women with polycystic ovary syndrome.
    Colak R; Keleştimur F; Unlühizarci K; Bayram F; Sahin Y; Tutuş A
    Eur J Endocrinol; 2002 Oct; 147(4):473-7. PubMed ID: 12370108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.